Protective effect of quercitrin against hydrogen peroxide-induced dysfunction in osteoblastic MC3T3-E1 cells

Experimental and Toxicologic Pathology

Volumn 64, Issue 3, 2012, Pages 211-216

  Choi, Eun Mi ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Osteoblast differentiation; Oxidative stress; Quercitrin

Indexed keywords

3 NITROTYROSINE; ALKALINE PHOSPHATASE; CARBONYL DERIVATIVE; COLLAGEN; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; QUERCITRIN;

ANIMAL CELL; ARTICLE; BONE DISEASE; BONE MINERALIZATION; CALCIUM CELL LEVEL; CELL DAMAGE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ESTROGEN ACTIVITY; INFLAMMATORY DISEASE; INTRACELLULAR SIGNALING; NONHUMAN; OSTEOBLAST; OSTEOCLASTOGENESIS; OXIDATIVE STRESS;

ANIMALS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYDROGEN PEROXIDE; MICE; OSTEOBLASTS; OXIDANTS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; QUERCETIN; SIGNAL TRANSDUCTION;

EID: 84857032636     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.08.008     Document Type: Article

References (26)

1. Bai X.C., Lu D., Bai J., Zheng H., Ke Z.Y., Li X.M., Luo S.Q. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun 2004, 314:197-207.
2. Banerjee T., Valacchi G., Ziboh V.A., van der Vliet A. Inhibition of TNF alpha-induced cyclooxygenase-2 expression by amentoflavone through suppression of NF-kappa B activation in A549 cells. Mol Cell Biochem 2002, 238:105-110.
3. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, 271:C1424-C1437.
4. Bi Y., Nielsen K.L., Kilts T.M., Yoon A., Karsdal M.A., Wimer H.F., Greenfield E.M., Heegaard A.M., Young M.F. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bone 2005, 38:778-786.
5. Blakeman D.P., Jolly R.A., Petry T.W. Diquat-dependent protein carbonyl formation: identification of lipid-dependent and lipid-independent pathways. Biochem Pharmacol 1995, 50:929-935.
6. Cruz E.A., Da-Silva S.A., Muzitano M.F., Silva P.M., Costa S.S., Rossi-Bergmann B. Immunomodulatory pretreatment with Kalanchoe pinnata extract and its quercitrin flavonoid effectively protects mice against fatal anaphylactic shock. Int Immunopharmacol 2008, 8:1616-1621.
7. De Wilde A., Heberden C., Chaumaz G., Bordat C., Lieberherr M. Signaling networks from Gbeta1 subunit to transcription factors and actin remodeling via a membrane-located ERbeta-related protein in the rapid action of daidzein in osteoblasts. J Cell Physiol 2006, 209:786-801.
8. De Wilde A., Lieberherr M., Colin C., Pointillart A. A low dose of daidzein acts as an ERb-selective agonist in trabecular osteoblasts of young female piglets. J Cell Physiol 2004, 200:253-262.
9. Esterbauer H. Estimation of peroxidative damage: a critical review. Pathol Biol 1996, 44:25-28.
10. Guicheux J., Lemonnier J., Ghayor C., Suzuki A., Palmer G., Caverzasio J. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res 2003, 18:2060-2068.
11. Hollman P.C., Katan M.B. Dietary Xavonoids: intake, health effects and bioavailability. Food Chem Toxicol 1999, 37:937-942.
12. Hu Y., Chan E., Wang S.X., Li B. Activation of p38 mitogen- activated kinase is required for osteoblast differentiation. Endocrinology 2003, 144:2068-2074.
13. Katso R., Okkenhaug K., Ahmadi K., White S., Timms J., Waterfield M.D. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2001, 17:615-675.
14. Kodama I., Niida S., Sanada M., Yoshiko Y., Tsuda M., Maeda N., Ohama K. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice. J Bone Miner Res 2004, 19:200-206.
15. Kuiper G.G.J.M., Lemmen J.G., Carlsson B., Corton J.C., Safe F.H., van der Saag P.T., van der Burg B., Guftasson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b. Endocrinology 1998, 139:4252-4263.
16. Maggio D., Barabani M., Pierandrei M., Polidori M.C., Catani M., Mecocci P. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 2003, 88:1523-1527.
17. Meyer A.S., Heinonen M., Frankel E.N. Antioxidant interactions of catechin, cyanidin, caffeic acid, quercetin, and ellagic acid on human LDL oxidation. Food Chem 1998, 61:71-75.
18. Mody N., Parhami F., Sarafian T.A., Demer L.L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001, 31:509-519.
19. Nakasaki M., Yoshioka K., Miyamoto Y., Sasaki T., Yoshikawa H., Itoh K. IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts. Bone 2008, 43:869-879.
20. Osyczka A.M., Leboy P.S. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 2005, 146:3428-3437.
21. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationships of Xavonoids and phenolic acids. Free Radic Biol Med 1996, 20:933-956.
22. Riggs B.L., Khosla S., Melton L.J. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002, 23:279-302.
23. Shinohara M., Takayanagi H. Novel osteoclast signaling mechanisms. Curr Osteoporos Rep 2007, 5:67-72.
24. Soberon J.R., Sgariglia M.A., Sampietro D.A., Quiroga E.N., Vattuone M.A. Antibacterial activity of plant extracts from northwestern Argentina. J Appl Microbiol 2007, 102:1450-1461.
25. Tullberg-Reinert H., Jundt G. In situ measurement of collagen synthesis by human bone cells with a Sirius Red-based colorimetric microassay: effects of transforming growth factor β2 and ascorbic acid 2-phosphate. Histochem Cell Biol 1999, 112:271-276.
26. Yoneda T., Ishimaru N., Arakaki R., Kobayashi M., Izawa T., Moriyama K., Hayashi Y. Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis. Endocrinology 2004, 145:2384-2391.